Bisdemethoxycurcumin-conjugated vitamin E TPGS liposomes ameliorate poor bioavailability of free form and evaluation of its analgesic and hypouricemic activity in oxonate-treated rats
Source abstract
Abstract
Recently, bisdemethoxycurcumin (BDMC), a constituent of turmeric, has been studied widely in view of their various therapeutic effects, namely anti-oxidant, anti-cancer, anti-diabetic, and anti-inflammatory. Since ancient times, turmeric has been extensively used as a naturally occurring traditional Chinese medicine (TCM) and as a crucial home remedy for treatment of many health problems such as inflammation and pain. However, the action of anti-gouty arthritis and analgesic activity of its constituents, especially BDMC, have not been scientifically reported yet. Despite the various bioactivities of BDMC, its utilization in clinics has been restricted owing to poor solubility and bioavailability. This research aimed at enhancing oral bioavailability and pharmacokinetic of BDMC via liposome formulation which was modified with d-α-tocopherol polyethylene glycol 1000 succinate (TPGS or vitamin E TPGS) and was characterized using various parameters both in vitro and in vivo. Also, the analgesic and anti-gouty activities of BDMC-loaded TPGS-modified liposomes were investigated by assessing pain threshold and serum uric acid level in potassium oxonate–induced hyperuricemic rats. As the result, BDMC-loaded TPGS-modified liposomes were formulated successfully with optimal physiochemical properties such as 75.98 ± 5.46 nm (particle size), 0.246 ± 0.011 (polydispersity index), − 38.21 ± 0.29 mV (zeta potential), 96.98 ± 0.17 (encapsulation efficiency (EE%)), and 4.84 ± 0.0089 (drug loading capacity (DL%)). Moreover, the oral bioavailability of liposomized BDMC was approximately 10-fold greater than free BDMC in vivo and in vitro cumulative release rates in pH 1.2 (78%) and pH 7 (68%) respectively. This significantly improved the sustaining drug effect of BDMC compared with free form. In addition, BDMC-TPGS liposome acted as a xanthine oxidase inhibitor to evidently reduce uric acid level in potassium oxonate–induced hyperuricemic rats and remarkably increase pain threshold capacity and reaction time in hot plate test at a dose-dependent manner. Altogether, BDMC-conjugated TPGS liposome could act as favorable nanocarriers against gouty arthritis and intense pain with prospect of overcoming the limitation of BDMC application.
Source: openaire · Quality: candidate unverified · Source record ↗
Research context
OpenAlex topics: Curcumin's Biomedical Applications · Advancements in Transdermal Drug Delivery · Synthesis and bioactivity of alkaloids
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (60)
Show source-provided references
1. Ahmed KS, Hussein SA, Ali AH, Korma SA, Lipeng Q, Jinghua C (2019) Liposome: composition, characterisation, preparation, and recent innovation in clinical applications. J Drug Target 27(7):742–761. https://doi.org/10.1080/1061186X.2018.152733710.1080/1061186X.2018.1527337 ↗
2. Ahuja BK, Jena SK, Paidi SK, Bagri S, Suresh S (2015) Formulation, optimization and in vitro–in vivo evaluation of febuxostat nanosuspension. Int J Pharm 478(2):540–552. https://doi.org/10.1016/j.ijpharm.2014.12.00310.1016/j.ijpharm.2014.12.003 ↗
3. Angeles, L., Angeles, L., & Haven, N. (2016). Phase 1 study of PSMA-targeted docetaxel-containing nanoparticle BIND-014 in patients with advanced solid tumors. Evidence before this study. We did not do a systematic review of the literature before initiating this trial . BIND-014’ s therapeutic. https://doi.org/10.1158/1078-0432.CCR-15-254810.1158/1078-0432.CCR-15-2548 ↗
4. Anto RJ, George J, Dinesh Babu KV, Rajasekharan KN, Kuttan R (1996) Antimutagenic and anticarcinogenic activity of natural and synthetic curcuminoids. Mutat Res - Genet Toxicol 370(2):127–131. https://doi.org/10.1016/0165-1218(96)00074-210.1016/0165-1218(96)00074-2 ↗
5. Asadabad MA, Eskandari MJ (2015) Transmission electron microscopy as best technique for characterization in nanotechnology. Synthesis Reactiv Inorganic, Metal-Organic Nano-Metal Chem 45(3):323–326. https://doi.org/10.1080/15533174.2013.83190110.1080/15533174.2013.831901 ↗
6. Baxa U (2018) Imaging of liposomes by transmission electron microscopy. In: Methods in Molecular Biology, vol 1682. Humana Press Inc, pp 73–88. https://doi.org/10.1007/978-1-4939-7352-1_810.1007/978-1-4939-7352-1_8 ↗
7. Becker MA, Jolly M (2006) Hyperuricemia and associated diseases. Rheum Dis Clin N Am 32(2):275–293. https://doi.org/10.1016/j.rdc.2006.02.00510.1016/j.rdc.2006.02.005 ↗
8. Bozzuto G (2015) Liposomes as nanomedical devices. Int J Nanomedicine 10:975–99910.2147/IJN.S68861 ↗
9. Byeon JC, Lee SE, Kim TH, Ahn JB, Kim DH, Choi JS, Park JS (2019) Design of novel proliposome formulation for antioxidant peptide, glutathione with enhanced oral bioavailability and stability. Drug Delivery 26(1):216–225. https://doi.org/10.1080/10717544.2018.155144110.1080/10717544.2018.1551441 ↗
10. Cabral H, Kataoka K (2014) Progress of drug-loaded polymeric micelles into clinical studies. J Control Release 190:465–476. https://doi.org/10.1016/j.jconrel.2014.06.04210.1016/j.jconrel.2014.06.042 ↗
11. Chao IC, Wang CM, Li SP, Lin LG, Ye WC, Zhang QW (2018) Simultaneous quantification of three curcuminoids and three volatile components of curcuma longa using pressurized liquid extraction and high-performance liquid chromatography. Molecules 23(7). https://doi.org/10.3390/molecules2307156810.3390/molecules23071568 ↗
12. Chen CJ, Lü JM, Yao Q (2016) Hyperuricemia-related diseases and xanthine oxidoreductase (XOR) inhibitors: an overview. Med Sci Monit. International Scientific Literature Inc. 22:2501–2512. https://doi.org/10.12659/MSM.89985210.12659/MSM.899852 ↗
13. Daily JW, Yang M, Park S (2016) Efficacy of Turmeric Extracts and Curcumin for Alleviating the Symptoms of Joint Arthritis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials. J Med Food 19(8):717–729. https://doi.org/10.1089/jmf.2016.370510.1089/jmf.2016.3705 ↗
14. Danaei M, Dehghankhold M, Ataei S, Hasanzadeh Davarani F, Javanmard R, Dokhani A et al (2018) Impact of particle size and polydispersity index on the clinical applications of lipidic nanocarrier systems. Pharmaceutics 10(2):1–17. https://doi.org/10.3390/pharmaceutics1002005710.3390/pharmaceutics10020057 ↗
15. Daraee H, Etemadi A, Kouhi M, Alimirzalu S, Akbarzadeh A (2016) Application of liposomes in medicine and drug delivery. Artif Cells, Nanomed Biotechnol 44(1):381–391. https://doi.org/10.3109/21691401.2014.95363310.3109/21691401.2014.953633 ↗
16. Delgado-Vargas F, Paredes-Lopez O (2002) Natural colorants for food and nutraceutical uses. CRC Press Retrieved from https://books.google.com/books?id=zXLLBQAAQBAJ&pg=PA24410.1201/9781420031713 ↗
17. Drahansky, M., Paridah, M. ., Moradbak, A., Mohamed, A. ., Owolabi, F. Abdulwahab Taiwo, Asniza, M., & Abdul Khalid, S. H. (2016). We are IntechOpen , the world’ s leading publisher of Open Access books Built by scientists, for scientists TOP 1 %. Intech, i(tourism), 13. https://doi.org/10.5772/5735310.5772/57353 ↗
18. Fan S, Zhang P, Wang AY, Wang X, Wang L, Li G, Hong D (2019) Hyperuricemia and its related histopathological features on renal biopsy. BMC Nephrol 20(1). https://doi.org/10.1186/s12882-019-1275-410.1186/s12882-019-1275-4 ↗
19. Gang W, Jie WJ, Ping ZL, Ming DS, Ying LJ, Lei W, Fang Y (2012) Liposomal quercetin: evaluating drug delivery in vitro and biodistribution in vivo. Expert Opinion Drug Delivery 9(6):599–613. https://doi.org/10.1517/17425247.2012.67992610.1517/17425247.2012.679926 ↗
20. Gómez-murcia V, Ribeiro B, Couto D, Gómez-fernández JC, Gómez-fernández JC (2019) Liposome-encapsulated morphine affords a prolonged analgesia while facilitating extinction of reward and aversive memories. Front Pharmacol 10(September):1–15. https://doi.org/10.3389/fphar.2019.0108210.3389/fphar.2019.01082 ↗
21. Guo Y, Luo J, Tan S, Otieno BO, Zhang Z (2013) The applications of vitamin E TPGS in drug delivery. Eur J Pharm Sci 49(2):175–186. https://doi.org/10.1016/j.ejps.2013.02.00610.1016/j.ejps.2013.02.006 ↗
22. Honary S, Zahir F (2013) Effect of zeta potential on the properties of nano-drug delivery systems - a review (part 1). Trop J Pharm Res 12(April):255–264
23. Hua S, Wu SY (2013) The use of lipid-based nanocarriers for targeted pain therapies. Front Pharmacol 4(November):1–7. https://doi.org/10.3389/fphar.2013.0014310.3389/fphar.2013.00143 ↗
24. Huang Q, Yu J, Zhang X, Liu S, Ge Y (2016) Association of the serum uric acid level with liver histology in biopsy-proven non-alcoholic fatty liver disease. Biomed Reports 5(2):188–192. https://doi.org/10.3892/br.2016.69810.3892/br.2016.698 ↗
25. Jaruvongvanich V, Ahuja W, Wirunsawanya K, Wijarnpreecha K, Ungprasert P (2017) Hyperuricemia is associated with nonalcoholic fatty liver disease activity score in patients with nonalcoholic fatty liver disease: a systematic review and meta-analysis. Eur J Gastroenterol Hepatol 29(9):1031–1035. https://doi.org/10.1097/MEG.000000000000093110.1097/MEG.0000000000000931 ↗
26. Jayaprakasha GK, Rao LJ, Sakariah KK (2006) Food chemistry antioxidant activities of curcumin, demethoxycurcumin and bisdemethoxycurcumin. Food Chem 98:720–724. https://doi.org/10.1016/j.foodchem.2005.06.03710.1016/j.foodchem.2005.06.037 ↗
27. Jin F, Jin Y, Du J, Jiang L, Zhang Y, Zhao Z et al (2019) Bisdemethoxycurcumin protects against renal fibrosis via activation of fibroblast apoptosis. Eur J Pharmacol 847(October 2018):26–31. https://doi.org/10.1016/j.ejphar.2019.01.01210.1016/j.ejphar.2019.01.012 ↗
28. Khan AA, Allemailem KS, Almatroodi SA, Almatroudi A, Rahmani AH (2020) Recent strategies towards the surface modification of liposomes: an innovative approach for different clinical applications. 3 Biotech 10:163. https://doi.org/10.1007/s13205-020-2144-310.1007/s13205-020-2144-3 ↗
29. Kong R, Kang OKHWA, Seo YUNSOO, Zhou T (2018) MAPKs and NF - κ B pathway inhibitory effect of bisdemethoxycurcumin on phorbol - 12 - myristate - 13 - acetate and A23187 - induced inflammation in human mast cells. Mol Med Rep 17:630–635. https://doi.org/10.3892/mmr.2017.785210.3892/mmr.2017.7852 ↗
30. Lai C-S, Chen Y-Y, Lee P-S, Kalyanam N, Ho C-T, Liou W-S et al (2016) Bisdemethoxycurcumin inhibits adipogenesis in 3T3-L1 preadipocytes and suppresses obesity in high-fat diet-fed C57BL/6 mice. J Agric Food Chem 64(4):821–830. https://doi.org/10.1021/acs.jafc.5b0557710.1021/acs.jafc.5b05577 ↗
31. Lee PJ, Woo SJ, Jee J, Sung SH, Kim HP (2015) Bisdemethoxycurcumin induces apoptosis in activated hepatic stellate cells via cannabinoid receptor 2. Molecules 20:1277–1292. https://doi.org/10.3390/molecules2001127710.3390/molecules20011277 ↗
32. Li X (2014) An efficient Trojan delivery of tetrandrine by poly ( N-vinylpyrrolidone ) -block- shows enhanced apoptotic induction of lung cancer cells and inhibition of its migration and invasion. Int J Nanomedicine 9:231–242
33. Li X, Huo C, Xiao Y, Xu R, Liu Y, Jia X, Wang X (2019a) Bisdemethoxycurcumin protection of cardiomyocyte mainly depends on Nrf2/HO - 1 activation mediated by the PI3K/AKT pathway. Chem Res Toxicol 32:1871–1879. https://doi.org/10.1021/acs.chemrestox.9b0022210.1021/acs.chemrestox.9b00222 ↗
34. Li Y, Tan X, Liu X, Liu L, Fang Y, Rao R et al (2019b) Title page Enhanced anticancer effect of doxorubicin by TPGS-coated liposomes with Bcl-2 siRNA-corona for dual suppression of drug resistance. Asian J Pharmaceut Sci. https://doi.org/10.1016/j.ajps.2019.10.00310.1016/j.ajps.2019.10.003 ↗
35. Li H, Yan L, Tang EKY, Zhang Z, Chen W, Liu G, Mo J (2019c) Synthesis of TPGS/curcumin nanoparticles by thin-film hydration and evaluation of their anti-colon cancer efficacy in vitro and in vivo. Front Pharmacol 10(July):1–12. https://doi.org/10.3389/fphar.2019.0076910.3389/fphar.2019.00769 ↗
36. Limtrakul P, Anuchapreeda S, Bhudsuk D (2005) Modulation of human multidrug-resistance MDR-1 gene by natural curcuminoids. Acta Hortic 678:75–83. https://doi.org/10.17660/ActaHortic.2005.678.910.17660/ActaHortic.2005.678.9 ↗
37. Luo C, Du Z, Wei X, Chen G, Fu Z (2015) Bisdemethoxycurcumin attenuates gastric adenocarcinoma growth by inducing mitochondrial dysfunction. Oncol Lett 9:270–274. https://doi.org/10.3892/ol.2014.268510.3892/ol.2014.2685 ↗
38. Malatesta M (2016) Transmission electron microscopy for nanomedicine: novel applications for long-established techniques. Eur J Histochem 60(4):8–12. https://doi.org/10.4081/ejh.2016.275110.4081/ejh.2016.2751 ↗
39. Mu L, Feng SS (2002) Vitamin E TPGS used as emulsifier in the solvent evaporation/extraction technique for fabrication of polymeric nanospheres for controlled release of paclitaxel (Taxol®). J Control Release 80(1–3):129–144. https://doi.org/10.1016/S0168-3659(02)00025-110.1016/S0168-3659(02)00025-1 ↗
40. Mukherjee S, Ray S, Thakur RS (2009, February 1) Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci. Wolters Kluwer -- Medknow Publications. https://doi.org/10.4103/0250-474X.5728210.4103/0250-474X.57282 ↗
41. Muthu MS, Kulkarni SA, Xiong J, Feng SS (2011) Vitamin e TPGS coated liposomes enhanced cellular uptake and cytotoxicity of docetaxel in brain cancer cells. Int J Pharm 421(2):332–340. https://doi.org/10.1016/j.ijpharm.2011.09.04510.1016/j.ijpharm.2011.09.045 ↗
42. Ohno I (2011) Relationship between hyperuricemia and chronic kidney disease. Nucleosides Nucleotides Nucleic Acids 30(12):1039–1044. https://doi.org/10.1080/15257770.2011.61148410.1080/15257770.2011.611484 ↗
43. Omosa LK, Midiwo JO, Kuete V (2017) Curcuma longa medicinal spices and vegetables from Africa: therapeutic potential against metabolic, inflammatory, infectious and systemic diseases. Elsevier Inc. https://doi.org/10.1016/B978-0-12-809286-6.00019-410.1016/B978-0-12-809286-6.00019-4 ↗
44. Ong SGM, Ming LC, Lee KS, Yuen KH (2016) Influence of the encapsulation efficiency and size of liposome on the oral bioavailability of griseofulvin-loaded liposomes. Pharmaceutics 8(3). https://doi.org/10.3390/pharmaceutics803002510.3390/pharmaceutics8030025 ↗
45. Paramasivam M, Poi R, Banerjee H, Bandyopadhyay A (2009) High-performance thin layer chromatographic method for quantitative determination of curcuminoids in Curcuma longa germplasm. Food Chem 113(2):640–644. https://doi.org/10.1016/j.foodchem.2008.07.05110.1016/j.foodchem.2008.07.051 ↗
46. Patil S, Sandberg A, Heckert E, Self W, Seal S (2007) Protein adsorption and cellular uptake of cerium oxide nanoparticles as a function of zeta potential. Biomaterials 28(31):4600–4607. https://doi.org/10.1016/j.biomaterials.2007.07.02910.1016/j.biomaterials.2007.07.029 ↗
47. Ponnusamy S, Zinjarde S, Bhargava S, Rajamohanan PR, Ravikumar A (2012) Discovering bisdemethoxycurcumin from Curcuma longa rhizome as a potent small molecule inhibitor of human pancreatic a -amylase, a target for type-2 diabetes. Food Chem 135(4):2638–2642. https://doi.org/10.1016/j.foodchem.2012.06.11010.1016/j.foodchem.2012.06.110 ↗
48. Rajebahadur M, Zia H, Nues A, Lee C (2006) Mechanistic study of solubility enhancement of nifedipine using vitamin E TPGS or solutol HS-15. Drug Deliver: J Deliver Target Therapeut Agents 13(3):201–206. https://doi.org/10.1080/1071754050031609410.1080/10717540500316094 ↗
49. Ramsewak RS, DeWitt DL, Nair MG (2000) Cytotoxicity, antioxidant and anti-inflammatory activities of curcumins I-III from Curcuma longa. Phytomedicine 7(4):303–308. https://doi.org/10.1016/S0944-7113(00)80048-310.1016/S0944-7113(00)80048-3 ↗
50. Saarinen-Savolainen P, Järvinen T, Taipale H, Urtti A (1997) Method for evaluating drug release from liposomes in sink conditions. Int J Pharm 159(1):27–33. https://doi.org/10.1016/S0378-5173(97)00264-010.1016/S0378-5173(97)00264-0 ↗
51. Sercombe L, Veerati T, Moheimani F, Wu SY, Sood AK, Hua S (2015) Advances and challenges of liposome assisted drug delivery. Front Pharmacol 6(DEC):1–13. https://doi.org/10.3389/fphar.2015.0028610.3389/fphar.2015.00286 ↗
52. Sezer AD, Akbuǧa J, Baş AL (2007) In vitro evaluation of enrofloxacin-loaded MLV liposomes. Drug Delivery 14(1):47–53. https://doi.org/10.1080/1071754060064014610.1080/10717540600640146 ↗
53. Singh, A., Saharan, V. A., Singh, M., & Bhandari, A. (2011). Phytosome: drug delivery system for polyphenolic phytoconstituents. Iranian Journal of Pharmaceutical Sciences Autumn (Vol. 7). Iranian Association of Pharmaceutical Scientists. Retrieved from http://www.ijps.ir/article_1834.html
54. Solomon D, Gupta N, Mulla NS, Shukla S, Guerrero YA, Gupta V (2017) Role of in vitro release methods in liposomal formulation development: challenges and regulatory perspective. AAPS J 19(6):1669–1681. https://doi.org/10.1208/s12248-017-0142-010.1208/s12248-017-0142-0 ↗
55. Vijayakumar A, Baskaran R, Jang YS, Oh SH, Yoo BK (2016) Quercetin-loaded solid lipid nanoparticle dispersion with improved physicochemical properties and cellular uptake. AAPS PharmSciTech 25. https://doi.org/10.1208/s12249-016-0573-410.1208/s12249-016-0573-4 ↗
56. Wang YZ, Xiao YQ, Zhang C, Sun XM (2009) Study of analgesic and anti-inflammatory effects of lappaconitine gelata. J Tradit Chin Med 29(2):141–145. https://doi.org/10.1016/S0254-6272(09)60051-010.1016/S0254-6272(09)60051-0 ↗
57. Wu L, Qiao Y, Wang L, Guo J, Wang G, He W et al (2015) A Self-microemulsifying Drug Delivery System (SMEDDS) for a novel medicative compound against depression: a preparation and bioavailability study in rats. AAPS PharmSciTech 16(5):1051–1058. https://doi.org/10.1208/s12249-014-0280-y10.1208/s12249-014-0280-y ↗
58. Yang C, Wu T, Qi Y, Zhang Z (2018) Recent advances in the application of vitamin E TPGS for drug delivery. Theranostics 8(2):464–485. https://doi.org/10.7150/thno.2271110.7150/thno.22711 ↗
59. Yodkeeree S, Chaiwangyen W, Garbisa S, Limtrakul P (2009) Curcumin, demethoxycurcumin and bisdemethoxycurcumin differentially inhibit cancer cell invasion through the down-regulation of MMPs and uPA ☆. J Nutr Biochem 20(2):87–95. https://doi.org/10.1016/j.jnutbio.2007.12.00310.1016/j.jnutbio.2007.12.003 ↗
60. Zhang Z, Feng SS (2006) The drug encapsulation efficiency, in vitro drug release, cellular uptake and cytotoxicity of paclitaxel-loaded poly(lactide)-tocopheryl polyethylene glycol succinate nanoparticles. Biomaterials 27(21):4025–4033. https://doi.org/10.1016/j.biomaterials.2006.03.00610.1016/j.biomaterials.2006.03.006 ↗